In-vivo T-cell depletion with pretransplant anti-thymocyte globulin (ATG) reduces GvHD without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors

被引:0
|
作者
Kröger, N
Zabelina, T
Krüger, W
Renges, H
Rischewski, J
Ayukatan, F
Tögel, F
Sonnenberg, S
Fiegel, H
Erttmann, R
Schade, U
Zander, A
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O253
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [41] Anti-thymocyte globulin (ATG) significantly reduces the incidence of moderate to severe chronic graft versus host disease in allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-matched sibling donor
    Park, S.
    Kim, K.
    Jang, J. H.
    Kim, S. J.
    Kim, W. S.
    Jung, C. W.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S200 - S200
  • [42] Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation
    Zider, Laura A.
    Seddon, Amanda N.
    Nathan, Sunita
    Maciejewski, John J.
    Shammo, Jamile M.
    Akpek, Gorgun
    [J]. BLOOD, 2016, 128 (22)
  • [43] Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Final Results and Analysis of Prognostic Factors.
    Finke, Jurgen
    Schmoor, Claudia
    Bethge, Wolfgang Andreas
    Ottinger, Hellmut
    Stelljes, Matthias
    Zander, Axel R.
    Volin, Liisa
    Heim, Dominik
    Schwerdtfeger, Rainer
    Bertz, Hartmut
    Grishina, Olga
    Socie, Gerard
    [J]. BLOOD, 2010, 116 (21) : 535 - 535
  • [44] Effect of in vivo T-cell depletion with ATG on cytomegalovirus (CMV) induced antileukemic effect in patients with acute myeloid leukemia (AML) receiving grafts from unrelated donors
    Busca, A.
    Dellacasa, C.
    Frairia, C.
    Aydin, S.
    Passera, R.
    Pini, M.
    Zallio, F.
    Audisio, E.
    Giaccone, L.
    Maffini, E.
    Costa, C.
    Cavallo, R.
    Manetta, S.
    Bruno, B.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S259 - S259
  • [45] Alpha/Beta T-cell Depleted Allogenic Stem Cell Transplantation from Matched Related and Unrelated Donor Grafts in Patients with Poor Risk Leukemia
    de Witte, Moniek
    van der Wagen, Lotte
    Slaper-Cortenbach, Ineke
    Kuball, Jurgen
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S277 - S278
  • [46] Lower Absolute Lymphocyte Count Before Conditioning Predicts High Relapse Risk in Patients After Haploidentical Peripheral Blood Stem Cell Transplantation With Low Dose Anti-Thymocyte Globulin/Post-Transplant Cyclophosphamide for GvHD Prophylaxis
    Zhou, Xiao
    Cai, Yu
    Yang, Jun
    Tong, Yin
    Qiu, Huiying
    Huang, Chongmei
    Zhou, Kun
    Xu, Xiaowei
    Niu, Jiahua
    Xia, Xinxin
    Zhang, Ying
    Shen, Chang
    Wei, Yu
    Song, Xianmin
    Wan, Liping
    [J]. CELL TRANSPLANTATION, 2022, 31
  • [47] IN VIVO T CELL DEPLETION WITH DEXAMETHASONE REDUCES GRAFT VERSUS HOST DISEASE (GVHD) WITH MINIMAL SIDE EFFECTS AND NO ADDITIONAL RISK OF EARLY RELAPSE AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL (PBSC) TRANSPLANTATION
    Innis-Shelton, R. D.
    Ashraff, K.
    Li, Y.
    Mehta, N.
    Salzman, D. E.
    Tilden, A.
    Vaughan, W. P.
    Lamb, L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S154 - S154
  • [48] Chronic Graft-Versus-Host Disease: Lessons From a Randomized Trial on GvHD Prophylaxis with or without Anti-T-Cell Globulin ATG-Fresenius (ATG-F) In Allogeneic Hematopoietic Cell Transplantation (HSCT) From Matched Unrelated Donors
    Socie, Gerard
    Schmoor, Claudia
    Bethge, Wolfgang Andreas
    Ottinger, Hellmut
    Stelljes, Matthias
    Zander, Axel R.
    Volin, Liisa
    Heim, Dominik
    Schwerdtfeger, Rainer
    Bertz, Hartmut
    Grishina, Olga
    Finke, Jurgen
    [J]. BLOOD, 2010, 116 (21) : 98 - 98
  • [49] Comparison of Two Kinds of Anti-Thymocyte Globulin on Outcomes of Haploidentical Stem Cell Transplantation For Refractory/Relapsed and High-Risk B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy
    Zhao, Zhao-Yanli
    Zhang, Jian-Ping
    Liu, De-Yan
    Wei, Zhi-Jie
    Xiong, Min
    Sun, Rui-Juan
    Zhou, Jia-Rui
    Lu, Yue
    Cao, Xing-Yu
    Zhang, Xian
    Yang, Jun-Fang
    Lu, Pei-Hua
    Lu, Dao-Pei
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 41 - 42
  • [50] Radiation-free reduced-intensity hematopoietic stem cell transplantation with in vivo T-cell depletion from matched related and unrelated donors for Fanconi anemia: prognostic factor analysis
    Rostami, Tahereh
    Mousavi, Seyed Ali
    Kiumarsi, Azadeh
    Kasaeian, Amir
    Rad, Soroush
    Yaghmaie, Marjan
    Ghavamzadeh, Ardeshir
    Mousavi, Seied Asadollah
    [J]. EXPERIMENTAL HEMATOLOGY, 2022, 109 : 27 - 34